EMA: PRAC concludes eye condition NAION is a very rare side effect of semaglutide medicines Ozempic, Rybelsus and Wegovy. Treatment with semaglutide should be stopped if NAION occurs 6 giugno 2025
6 giugno 2025
Leggi
Breaking news
Kidney disease: the forgotten legacy of type 1 diabetes
Thomas MC, Zoungas S, Hanssen NMJ, et al.
Diabetes Care. 2025:dci250028.
Leggi
Copenhagen declaration: a blueprint for diabetes care and research in an interconnected world
Beyh YS, Bergman M, Chan JCN et al.
The Global Diabetes Forum (GDF). Pub. online 30 May 2025.
Leggi
Metabolic dysfunction-associated steatotic liver disease (MASLD) in people with diabetes: the need for screening and early intervention. A consensus report of the American Diabetes Association
Cusi K, Abdelmalek MF, Apovian CM, et al.
Diabetes Care. 2025:dci240094.
Leggi
Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society
Mozaffarian D, Agarwal M, Aggarwal M, et al.
Obesity (Silver Spring). Pub. online 30 May 2025.
Leggi
Prevention of diabetic ketoacidosis in relatives screened for islet autoantibodies and followed up in the TrialNet Pathway to Prevention study at a single institution in Italy
Martinenghi S, Merolla A, Grogan P, et al.
Diabetologia. Pub. online 29 May 2025.
Leggi
Initiation of continuous glucose monitoring and mortality in type 2 diabetes
Reaven PD, Macwan S, Newell M, et al.
Diabetes Technol Ther. Pub. online 28 May 2025.
Leggi
Once-weekly mazdutide in chinese adults with obesity or overweight
Ji L, Jiang H, Bi Y, et al.
N Engl J Med. Pub. online 25 May 2025.
Leggi
The impact of insulin pump therapy compared to multiple daily injections on complications and mortality in type 1 diabetes: a real-world retrospective cohort study
Haughton S, Riley D, Berry S, et al.
Diabetes Obes Metab. Pub. online 19 May 2025.
Leggi
Glucose-lowering medications, glycemia, and cognitive outcomes: the GRADE randomized clinical trial
Luchsinger JA, Rosin SP, Kazemi EJ, et al.
JAMA Intern Med. 2025:e251189.
Leggi